Point Of Care Diagnostics Articles & Analysis
48 news found
” “With this MRI, healthcare professionals in Canada now have the ability to more broadly provide point-of-care diagnostics for patients in a variety of urgent settings,” continued Cameron Piron. “As with our entire suite of surgical and diagnostic products, our goal is to provide surgeons and healthcare ...
Entegrion Announces CE Mark for Point of Care System for Blood Coagulation Monitoring. Regulatory clearance makes Entegrion’s innovative point of care diagnostic instrument for viscoelastic coagulation testing available to clinicians in Europe. ...
Anavasi Diagnostics ('Anavasi'), a medical technology company focused on the development of novel molecular diagnostic testing, recently announced the addition of a Chief Financial Officer, Chief Operating Officer and Chief Commercial Officer to its management roster. ...
Founded in 2009 and headquartered in Boulder, Colorado, LightDeck has developed a scalable and innovative platform for rapid and accurate point of care diagnostics. LightDeck’s 80-member team includes industry veterans, engineers, and scientists, with deep technical expertise in assay development, manufacturing, and software development, ...
As a member of Alveo’s SAB Soistman will leverage his proven track record leading and governing healthcare businesses to provide strategic support in Alveo’s efforts to bring to market the company’s be.well™ platform, a point-of-care and at-home diagnostic tool currently under development. ...
Virusight Diagnostic, a world leader in combining artificial intelligence software and spectral technology today announced the results of a major clinical study that found its ultra-rapid, point of care Pathogens Diagnostic solution consistently delivers 96.3% accuracy when compared to the gold standard RT-PCR. ...
Pankaj Jain at Arizona Urology said, “With our goal to offer the most advanced prostate cancer diagnostics and treatment platform, Arizona Urology is now excited to integrate the Promaxo MRI system into our practice in order to administer the best diagnostic biopsy and treatment plans to our patients. ...
In developing and commercializing its in-office MRI system, we are pleased to provide strategic financing and support to Promaxo, as it is addressing a large, unmet need in office-based patient care. On favorable physician feedback and demand, we look forward to Promaxo’s progress as it drives market penetration of its system, advancing cancer diagnosis and ...
Visby Medical, Inc. an innovative diagnostic company, today announced its agreement with Urgent Care for Children (UC4C) to offer the company’s new Sexual Health Click Test to patients for the detection of sexually transmitted infections (STIs) in female patients 14 years of age and older. ...
Amit Gupta at Beverly Hills Urology said, “Our practice is dedicated to leveraging the latest technologies and techniques that advance patient care. In partnering with Promaxo, we are bringing minimally invasive, office based MRI to Beverly Hills, California, with a clinical focus on MR guided biopsies and treatments such as high intensity focused ultrasound (HIFU) of the ...
” “It is with pleasure that we welcome Arizona State Urological Institute to our growing network of physician practices, as we seek to enable safe and effective point of care diagnostic biopsies and treatment of prostate cancer with our innovational MRI system. ...
Anavasi Diagnostics announced today that it has submitted the required EUA Clinical Study Data for the AscencioDx®, the molecular diagnostic platform for the detection of RNA indicative of the presence of the SARS-CoV-2/COVID-19 virus, to the Food and Drug Administration (FDA). ...
Company poised to disrupt $80 billion U.S. clinical laboratory market Chronus Health, a point-of-care diagnostics company, announced today that it has raised $22 million Series A financing led by Tarsadia Investments with participation from Monta Vista Capital, SOSV, Savantus Ventures, and an undisclosed strategic investor. ...
Visby Medical™, a leading medical diagnostic company, today announced Terri Bresenham and Scott Mendel have been appointed to the company’s Board of Directors. ...
“Our technology enables safe and effective point of care diagnostic biopsies and treatment of cancers, overcoming limitations of traditional MRIs, and paving way for our $3 billion addressable market for in-office prostate procedures. We are thrilled to welcome Kasraeian Urology to our growing network of physician practices and look forward ...
By bringing together Quidel’s point-of-care diagnostics with Ortho’s vast global reach, there is a substantial opportunity to capitalize on the cross-selling opportunities, move into attractive adjacent markets, and accelerate innovative product expansion and the development of molecular technologies,” said Chris Smith, Chairman ...
The European Investment Bank (EIB) has signed a €20 million loan agreement with Belgian diagnostics company miDiagnostics, to support its research and development activities targeting infectious diseases, and in particular the scale-up of its new rapid COVID-19 PCR Test. ...
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced the opening of a United States subsidiary in the Denver metropolitan area. ...
We’re able to illuminate the sample faster without the additional process steps that are typically required.” Preceding point-of-care diagnostic systems have had trouble balancing accuracy and cost. “The trick is to meet the performance requirements of your central laboratory testing while still having the affordability and ...
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™ SARS-CoV-2 Rapid Antigen Test. ...